@article{30b689ad6fe94ef5a44eff7681090e5a,
title = "Role of GCN2-independent signaling through a noncanonical PERK/NRF2 pathway in the physiological responses to dietary methionine restriction",
abstract = "Restricting availability of essential amino acids (EAAs) limits aminoacylation of tRNAs by their cognate EAAs and activates the nutrient-sensing kinase, general control nonderepressible 2 (GCN2). Activated GCN2 phosphorylates eukaryotic initiation factor 2 (eIF2), altering gene-specific translation and initiating a transcriptional program collectively described as the integrated stress response (ISR). Central GCN2 activation by EAA deprivation is also linked to an acute aversive feeding response. Dietary methionine restriction (MR) produces a well-documented series of physiological responses (increased energy intake and expenditure, decreased adiposity, and increased insulin sensitivity), but the role of GCN2 in mediating them is unknown. Using Gcn2-/- mice, we found that the absence of GCN2 had no effect on the ability of MR to reduce body weight or adiposity, increase energy intake and expenditure, increase hepatic transcription and release of fibroblast growth factor 21, or improve insulin sensitivity. Interestingly, hepatic eIF2 phosphorylation by MR was uncompromised in Gcn2-/- mice. Instead, protein kinase R-like endoplasmic reticulum (ER) kinase (PERK) was activated in both intact and Gcn2-/- mice. PERK activation corresponded with induction of the ISR and the nuclear respiratory factor 2 antioxidant program but not ER stress. These data uncover a novel glutathionesensing mechanism that functions independently of GCN2 to link dietary MR to its metabolic phenotype.",
author = "Desiree Wanders and Stone, {Kirsten P.} and Forney, {Laura A.} and Cortez, {Cory C.} and Dille, {Kelly N.} and Jacob Simon and Mark Xu and Hotard, {Elisabeth C.} and Nikonorova, {Inna A.} and Pettit, {Ashley P.} and Anthony, {Tracy G.} and Gettys, {Thomas W.}",
note = "Funding Information: The authors thank Cindi Tramonte for administrative support and Manda Orgeron, Alicia Pierse, Alexandra N. Daniel, and Phillip H. Behrens for excellent technical support. Cindi Tramonte, Manda Orgeron, and Alicia Pierce are at the Pennington Biomedical Research Center (Baton Rouge, LA), and Alexandra N. Daniel and Phillip H. Behrens are in Biochemistry and Molecular Biology, Indiana University School of Medicine-Evansville, Evansville, IN. The authors thank Carrie Elks at Pennington Biomedical Research Center (Baton Rouge, LA) for her valuable input on Western blotting of PERK. This work was supported in part by the American Diabetes Association (1-12-BS-58 to T.W.G.), National Institutes of Health (NIH) (RO1-HD-070487 to T.G.A. and RO1-DK-096311 to T.W.G.), U.S. Department of Agriculture Cooperative State Research, Education, and Extension Service (Multistate NC1184 to T.G.A.), and the Vanderbilt University Mouse Metabolic Phenotyping Center (NIH U24-DK-059637). This work also made use of the Genomics core facilities supported by NIH P20-GM-103528 to T.W.G. and NIH 2P30-DK-072476. D.W. was supported by NIH National Research Service Award 1 F32-DK-098918 and NIH P20-GM-103528. L.A.F. is supported by an ADA mentor-based postdoctoral fellowship (7-13-MI-05). E.C.H. was supported by summer student fellowship (NIH 5T35OD011151). A.P.P. is supported by an NIH Institutional Research and Academic Career Development Award (New Jersey/New York for Science Partnerships in Research and Education at Rutgers-Robert Woods Johnson Medical School). Publisher Copyright: {\textcopyright} 2016 by the American Diabetes Association.",
year = "2016",
month = jun,
day = "1",
doi = "10.2337/db15-1324",
language = "English (US)",
volume = "65",
pages = "1499--1510",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "6",
}